Literature DB >> 17711975

Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.

Julie R Ostberg1, Baris E Dayanc, Min Yuan, Ezogelin Oflazoglu, Elizabeth A Repasky.   

Abstract

Circulating NK cells normally experience temperature gradients as they move about the body, but the onset of inflammation can expose them and their targets to febrile temperatures for several hours. We found that exposure of human peripheral blood NK cells and target cells to fever-range temperatures significantly enhances lysis of Colo205 target cells. A similar effect was not observed when NK cell lines or IL-2-activated peripheral blood NK cells were used as effectors, indicating that thermal sensitivity of effectors is maturation or activation state-dependent. Use of blocking antibodies revealed that this effect is also dependent on the function of the activating receptor NKG2D and its ligand MHC class I-related chain A (MICA). On NK cells, it was observed that thermal exposure does not affect the total level of NKG2D surface expression, but does result in its distinct clustering, identical to that which occurs following IL-2-induced activation. On tumor target cells, a similar, mild temperature elevation results in transcriptional up-regulation of MICA in a manner that correlates with increased sensitivity to cytolysis. Overall, these data reveal that NK cells possess thermally responsive regulatory elements, which facilitate their ability to capitalize on reciprocal, stress-induced changes simultaneously occurring on target cells during inflammation and fever.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711975     DOI: 10.1189/jlb.1106699

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activation.

Authors:  Evan R Zynda; Melissa J Grimm; Min Yuan; Lingwen Zhong; Thomas A Mace; Maegan Capitano; Julie R Ostberg; Kelvin P Lee; Arnd Pralle; Elizabeth A Repasky
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Fever and the thermal regulation of immunity: the immune system feels the heat.

Authors:  Sharon S Evans; Elizabeth A Repasky; Daniel T Fisher
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 3.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

4.  Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model.

Authors:  Maegan L Capitano; Giao Hangoc; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

5.  Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathway.

Authors:  Danish Umar; Arundhoti Das; Suman Gupta; Somdeb Chattopadhyay; Debayan Sarkar; Gauri Mirji; Jeet Kalia; Gopalakrishnan Aneeshkumar Arimbasseri; Jeannine Marie Durdik; Satyajit Rath; Anna George; Vineeta Bal
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

Review 6.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

7.  Winner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Maegan L Capitano; Bradley R Ertel; Elizabeth A Repasky; Julie R Ostberg
Journal:  Int J Hyperthermia       Date:  2008-03       Impact factor: 3.914

Review 8.  Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.

Authors:  Maryann E Mikucki; Daniel T Fisher; Amy W Ku; Michelle M Appenheimer; Jason B Muhitch; Sharon S Evans
Journal:  Int J Hyperthermia       Date:  2013-07-17       Impact factor: 3.914

Review 9.  Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia.

Authors:  Adrienne J Peer; Melissa J Grimm; Evan R Zynda; Elizabeth A Repasky
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

10.  Association of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.

Authors:  R Kopp; J Glas; U Lau-Werner; E D Albert; E H Weiss
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.